Publications by authors named "Burcin Simsek"

Claim this Profile
A
Administration of nivolumab plus ipilimumab: Infusion of the fixed-ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800).
Alexander M Menzies, Pamela Salman, Osvaldo Arén Frontera, David Pook, Christopher M Hocking, Burcin Simsek

Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial.
Robert J Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli, Burcin Simsek

J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary of quality of life in CheckMate 9ER: Cabozantinib plus nivolumab in advanced renal cell carcinoma.
David Cella, Robert J Motzer, Cristina Suarez, Steven I Blum, Flavia Ejzykowicz, Burcin Simsek

Future Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial.
Robert J Motzer, Paul Russo, Viktor Grünwald, Yoshihiko Tomita, Bogdan Zurawski, Burcin Simsek

Target Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.
Robert J Motzer, Paul Russo, Viktor Grünwald, Yoshihiko Tomita, Bogdan Zurawski, Burcin Simsek

Lancet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial.
Andrea B Apolo, Thomas Powles, Bernard Escudier, Mauricio Burotto, Joshua Zhang, Burcin Simsek

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial.
Robert J Motzer, Thomas Powles, Mauricio Burotto, Bernard Escudier, Maria T Bourlon, Burcin Simsek

Lancet Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial.
David Cella, Robert J Motzer, Cristina Suarez, Steven I Blum, Flavia Ejzykowicz, Burcin Simsek

Lancet Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Miscarriage determination in first trimester based on alpha-fetoprotein extracted from sanitary pads.
Amir Mor, Mursal Gardezi, Karen Jubanyik, Burcin Simsek, David B Seifer

Fertil Steril· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Status of racial disparities between black and white women undergoing assisted reproductive technology in the US.
David B Seifer, Burcin Simsek, Ethan Wantman, Alexander M Kotlyar

Reprod Biol Endocrinol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of female demographics in the United States: life expectancy, education, employment, family building decisions, and fertility service utilization.
Ecem Esencan, Burcin Simsek, Emre Seli

Curr Opin Obstet Gynecol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in ART Live Birth and Cumulative Live Birth Outcomes for Hispanic and Asian Women Compared to White Non-Hispanic Women.
Alexander M Kotlyar, Burcin Simsek, David B Seifer

J Clin Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Toni K Choueiri, Thomas Powles, Mauricio Burotto, Bernard Escudier, Maria T Bourlon, Burcin Simsek

N Engl J Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Status of racial disparities between black and white women undergoing assisted reproductive technology in the US.
David B Seifer, Burcin Simsek, Ethan Wantman, Alexander M Kotlyar

Reprod Biol Endocrinol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status of racial disparities between black and white women undergoing assisted reproductive technology in the US.
David B Seifer, Burcin Simsek, Ethan Wantman, Alexander M Kotlyar

Reprod Biol Endocrinol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial.
Padmanee Sharma, Russell K Pachynski, Vivek Narayan, Aude Fléchon, Gwenaelle Gravis, Burcin Simsek

Cancer Cell· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma.
Paolo Antonio Ascierto, Michele Del Vecchio, Andrzej Mackiewicz, Caroline Robert, Vanna Chiarion-Sileni, Burcin Simsek

J Immunother Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A step towards the automation of intracytoplasmic sperm injection: real time confirmation of mouse and human oocyte penetration and viability by electrical resistance measurement.
Amir Mor, Man Zhang, Ecem Esencan, Burcin Simsek, Stephanie M Nichols-Burns

Fertil Steril· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which Sleep Health Characteristics Predict All-Cause Mortality in Older Men? An Application of Flexible Multivariable Approaches.
Meredith L Wallace, Katie Stone, Stephen F Smagula, Martica H Hall, Burcin Simsek

Sleep· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma.
Birgit Geoerger, Christophe Bergeron, Lia Gore, Leonard Sender, Ira J Dunkel, Burcin Simsek

Eur J Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An approach to revealing clinically relevant subgroups across the mood spectrum.
Meredith L Wallace, Burcin Simsek, David J Kupfer, Holly A Swartz, Andrea Fagiolini

J Affect Disord· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis